Home
Services > In Vitro Fertilization
.
In Vitro Fertilization

.
Intracytoplasmic Sperm Injection
.
Sperm Retrieval (MESA/PESA/TESE)
.
Donor Eggs
.
Embryo Freezing (Cryopreservation)
.
Assisted Embryo Hatching
.
Blastocyst Transfer
.
Donor Insemination (DI)
.
Ovulation induction, superovulation and intrauterine insemination (IUI)
.
Male Infertility Services
.
Counseling and Support
.
Pre-Implantation Genetic Diagnosis (PGD)
.
Nuchal Screening
.

Printable Patient Info

English
Punjabi
Chinese

 
 


Nuchal Screening

What is Nuchal Screening?

It is a method of screening during early pregnancy to determine whether your baby is at low or high risk for being affected with Down Syndrome or certain other chromosome or heart abnormalities.

What does Nuchal Screening involve?

The testing involves an early pregnancy ultrasound between 11 and 14 weeks gestation to look at the area around your baby’s neck, followed by a blood test. At the time of this abdominal ultrasound, an assessment of your baby’s anatomy is also performed but this is limited because of the early gestational age.

What is a “nuchal translucency”?

Every fetus has some fluid present at the back of the neck. The thickness of this fluid can be measured and is called the nuchal translucency (NT) measurement. Fetuses affected by Down Syndrome often have an increased NT thickness as do some babies with other chromosome or heart abnormalities. The NT measurement plus the blood work will determine whether the pregnancy is “screen positive” or “screen negative”.

The arrow indicates the nuchal translucency.

What is “screen negative”?

The majority of pregnancies will be “screen negative” -- the results are reassuring and further testing for chromosome abnormalities is generally not advised. It is important to realize that being “screen negative” does not alter routine prenatal care.


What is “screen positive”?

Approximately 5% of pregnancies will be “screen positive”. This means that the fetus is at higher risk of having an abnormality and that further tests will be offered, such as amniocentesis or chorionic villus sampling (CVS). Being “screen positive” does not mean that the fetus has an abnormality, just that further testing may be needed. It is important to remember that most women that are “screen positive” actually have normal fetuses.

How do I get my results?

The results of your screening will be discussed with you either by telephone or in person by Dr. Jason Hitkari. If you are “screen positive”, counseling will be offered to help review the results and discuss the options.

How do I arrange to have the test done?

You may be referred by your health-care provider (midwife, family doctor or obstetrician), or you may refer yourself by calling (604) 879-3038 to book a time for the testing.

When is Nuchal Screening done?

It is important to note that testing can only be done between 11 and 14 weeks gestation. Booking should be done as early as possible. If you are close to 14 weeks, we will do our best to fit you in.

Who will be performing the testing?

Dr. Jason Hitkari is an Obstetrician/Gynecologist and Reproductive Endocrinology subspecialist who is licensed by the Fetal Medicine Foundation to perform NT measurements. He or the genetic counselor will contact you directly with the results of your testing and provide a copy to your health care provider.

What will my visit to Genesis be like?

We pride ourselves on being professional, courteous, and friendly. When you arrive at our facility, you will be asked to fill out a short history form about your medical and pregnancy history. You will then have an ultrasound done by Dr. Hitkari to obtain the NT measurement, confirm the pregnancy dates, and look at fetal anatomy. Once this is done, a finger-prick blood sample will be taken. The whole visit will take approximately one hour. Analysis of the blood work will take 2-3 days. Once those results are available, you and your health care provider will be notified of the results.

Is that all the testing that I will need during pregnancy?

It is very important to understand that routine prenatal care should continue as scheduled by your midwife, family doctor, or obstetrician. This will include another routine and detailed ultrasound between 18 and 20 weeks gestation. In addition, a blood test during the second trimester measuring alpha-fetoprotein should be completed to screen for neural tube defects. This will be arranged by the health care provider looking after you during the pregnancy. Any obstetric complications that arise during your pregnancy will be managed by your health care provider.



Back to Top

   

 

  ©2002 Genesis Fertility Centre. All rights reserved.